Head-to-head dispatch
EverSlim vs NextMeds
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
EverSlim is a US telehealth program selling doctor-prescribed compounded GLP-1 medication delivered to the door, with compounded semaglutide from $117 a month and compounded tirzepatide from $140 a month.
Marked down on: No price tiers are published anywhere: /pricing is a 404, the footer pricing link is a same-page anchor, and the checkout is behind a login, so what a titrated dose costs is unknowable before signing up
Desk Score
NextMeds is a cash-pay telehealth platform offering compounded semaglutide and compounded tirzepatide on a flat monthly membership — one price bundling the medication (if prescribed), telehealth visits, a…
Marked down on: Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
EverSlim takes this head-to-head with the higher Desk Score, 82/100 (B−) against 71/100 (C) for NextMeds. NextMeds still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
EverSlim
82/100
B−
NextMeds
71/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | EverSlim | NextMeds |
|---|---|---|
| Semaglutide | $117/mo (compounded) | $129/mo (plus a separate fee, compounded) |
| Tirzepatide | $140/mo (compounded) | $179/mo (plus a separate fee, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want budget-minded patients wanting flat-price compounded glp-1 care shipped nationwide. | Readers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian. |
| Desk Score | 82/100B− | 71/100C |
The verdict
Desk pick — EverSlimEverSlim takes this head-to-head with the higher Desk Score, 82/100 (B−) against 71/100 (C) for NextMeds. NextMeds still holds its ground where its strengths line up with yours.
Choose EverSlim if…
Readers who want budget-minded patients wanting flat-price compounded glp-1 care shipped nationwide.
$117/mo (compounded) sema · $140/mo (compounded) tirz · All 50 states
Choose NextMeds if…
Readers who want flat-price compounded semaglutide or tirzepatide bundled with a care coach and registered dietitian.
$129/mo (plus a separate fee, compounded) sema · $179/mo (plus a separate fee, compounded) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: EverSlim · NextMeds.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- EverSlim vs CoreAge Rx
- NextMeds vs Vaylen
- EverSlim vs Strut Health
- NextMeds vs Ondra Health
- EverSlim vs Invigor Medical
- NextMeds vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.